These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 38089577)
1. Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD. Yue F; Shi Y; Wu S; Xing L; He D; Wei L; Qiu A; Russell R; Zhang D iScience; 2023 Dec; 26(12):108560. PubMed ID: 38089577 [TBL] [Abstract][Full Text] [Related]
2. Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway. Guan Q; Wang Z; Hu K; Cao J; Dong Y; Chen Y Int J Biol Sci; 2023; 19(12):3937-3950. PubMed ID: 37564204 [TBL] [Abstract][Full Text] [Related]
4. Hepatic STAMP2 mediates recombinant FGF21-induced improvement of hepatic iron overload in nonalcoholic fatty liver disease. Kim HY; Kwon WY; Park JB; Lee MH; Oh YJ; Suh S; Baek YH; Jeong JS; Yoo YH FASEB J; 2020 Sep; 34(9):12354-12366. PubMed ID: 32721044 [TBL] [Abstract][Full Text] [Related]
5. Ferroportin-Dependent Iron Homeostasis Protects against Oxidative Stress-Induced Nucleus Pulposus Cell Ferroptosis and Ameliorates Intervertebral Disc Degeneration Lu S; Song Y; Luo R; Li S; Li G; Wang K; Liao Z; Wang B; Ke W; Xiang Q; Chen C; Wu X; Zhang Y; Ling L; Yang C Oxid Med Cell Longev; 2021; 2021():6670497. PubMed ID: 33628376 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH. Park JB; Ko K; Baek YH; Kwon WY; Suh S; Han SH; Kim YH; Kim HY; Yoo YH Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629045 [TBL] [Abstract][Full Text] [Related]
7. Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis. Wang Y; Bo J; Zhao Z; Han Y; Zhang Q; Liu L Life Sci; 2023 Nov; 332():122086. PubMed ID: 37714372 [TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis. Ding SB; Chu XL; Jin YX; Jiang JJ; Zhao X; Yu M Front Pharmacol; 2023; 14():1148814. PubMed ID: 37025486 [No Abstract] [Full Text] [Related]
9. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis. Guo T; Yan W; Cui X; Liu N; Wei X; Sun Y; Fan K; Liu J; Zhu Y; Wang Z; Zhang Y; Chen L Mol Med; 2023 Sep; 29(1):132. PubMed ID: 37770820 [TBL] [Abstract][Full Text] [Related]
10. Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota. Xu J; Tian H; Ji Y; Dong L; Liu Y; Wang Y; Gao X; Shi H; Li H; Yang L Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2687-2699. PubMed ID: 37126194 [TBL] [Abstract][Full Text] [Related]
11. Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis. Zhang T; Wang MY; Wang GD; Lv QY; Huang YQ; Zhang P; Wang W; Zhang Y; Bai YP; Guo LQ Eur J Pharmacol; 2024 Mar; 966():176341. PubMed ID: 38244761 [TBL] [Abstract][Full Text] [Related]
12. An overview of ferroptosis in non-alcoholic fatty liver disease. Wang S; Liu Z; Geng J; Li L; Feng X Biomed Pharmacother; 2022 Sep; 153():113374. PubMed ID: 35834990 [TBL] [Abstract][Full Text] [Related]
13. Ferroportin expression and regulation in human placenta/fetal membranes: Implications for ferroptosis and adverse pregnancy outcomes. Ng SW; Lee C; Ng A; Ng SK; Arcuri F; House MD; Norwitz ER Reprod Biol; 2023 Dec; 23(4):100816. PubMed ID: 37890398 [TBL] [Abstract][Full Text] [Related]
14. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease. Liu P; Anandhan A; Chen J; Shakya A; Dodson M; Ooi A; Chapman E; White E; Garcia JG; Zhang DD Redox Biol; 2023 Feb; 59():102570. PubMed ID: 36495698 [TBL] [Abstract][Full Text] [Related]
15. Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation. Li L; Wang K; Jia R; Xie J; Ma L; Hao Z; Zhang W; Mo J; Ren F Redox Biol; 2022 Oct; 56():102435. PubMed ID: 36029649 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells. Geng N; Shi BJ; Li SL; Zhong ZY; Li YC; Xua WL; Zhou H; Cai JH Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3826-3836. PubMed ID: 29949159 [TBL] [Abstract][Full Text] [Related]
17. Recombinant FGF21 Attenuates Polychlorinated Biphenyl-Induced NAFLD/NASH by Modulating Hepatic Lipocalin-2 Expression. Kim HY; Yoo YH Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012166 [TBL] [Abstract][Full Text] [Related]
18. Hepatic STAMP2 alleviates polychlorinated biphenyl-induced steatosis and hepatic iron overload in NAFLD models. Kim HY; Park CH; Park JB; Ko K; Lee MH; Chung J; Yoo YH Environ Toxicol; 2022 Sep; 37(9):2223-2234. PubMed ID: 35616167 [TBL] [Abstract][Full Text] [Related]
19. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109 [TBL] [Abstract][Full Text] [Related]
20. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease. Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]